Cargando…
Myocarditis following COVID-19 vaccination – A case series
There have been reports of myocarditis following COVID-19 vaccination. We surveyed all hospitalized military personnel in the Isareli Defense Forces during the period of the COVID-19 vaccination operation (12/28/2021–3/7/2021) for diagnosed myocarditis. We identified 7 cases of myocarditis with symp...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416687/ https://www.ncbi.nlm.nih.gov/pubmed/34535317 http://dx.doi.org/10.1016/j.vaccine.2021.09.004 |
_version_ | 1783748241767006208 |
---|---|
author | Levin, Dan Shimon, Gil Fadlon-Derai, Maggie Gershovitz, Liron Shovali, Amiram Sebbag, Anat Bader, Shakib Fink, Noam Gordon, Barak |
author_facet | Levin, Dan Shimon, Gil Fadlon-Derai, Maggie Gershovitz, Liron Shovali, Amiram Sebbag, Anat Bader, Shakib Fink, Noam Gordon, Barak |
author_sort | Levin, Dan |
collection | PubMed |
description | There have been reports of myocarditis following COVID-19 vaccination. We surveyed all hospitalized military personnel in the Isareli Defense Forces during the period of the COVID-19 vaccination operation (12/28/2021–3/7/2021) for diagnosed myocarditis. We identified 7 cases of myocarditis with symptoms starting in the first week after the second dose of COVID-19 Pfizer-BioNTech vaccine. One case of myocarditis diagnosed 10 days after the second dose of the vaccine was not included. These 8 cases comprise of all events of myocarditis diagnosed in military personnel during this time period. All patients were young and generally healthy. All had mild disease with no sequalae. The incidence of myocarditis in the week following a second dose of the vaccine was 5.07/100,000 people vaccinated. Due to the nature of this report no causality could be established. Clinicians should be aware of the possibility of myocarditis following Pfizer-BioNTech vaccination. True incidence rates should be further investigated. |
format | Online Article Text |
id | pubmed-8416687 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84166872021-09-07 Myocarditis following COVID-19 vaccination – A case series Levin, Dan Shimon, Gil Fadlon-Derai, Maggie Gershovitz, Liron Shovali, Amiram Sebbag, Anat Bader, Shakib Fink, Noam Gordon, Barak Vaccine Short Communication There have been reports of myocarditis following COVID-19 vaccination. We surveyed all hospitalized military personnel in the Isareli Defense Forces during the period of the COVID-19 vaccination operation (12/28/2021–3/7/2021) for diagnosed myocarditis. We identified 7 cases of myocarditis with symptoms starting in the first week after the second dose of COVID-19 Pfizer-BioNTech vaccine. One case of myocarditis diagnosed 10 days after the second dose of the vaccine was not included. These 8 cases comprise of all events of myocarditis diagnosed in military personnel during this time period. All patients were young and generally healthy. All had mild disease with no sequalae. The incidence of myocarditis in the week following a second dose of the vaccine was 5.07/100,000 people vaccinated. Due to the nature of this report no causality could be established. Clinicians should be aware of the possibility of myocarditis following Pfizer-BioNTech vaccination. True incidence rates should be further investigated. Elsevier Ltd. 2021-10-08 2021-09-04 /pmc/articles/PMC8416687/ /pubmed/34535317 http://dx.doi.org/10.1016/j.vaccine.2021.09.004 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Levin, Dan Shimon, Gil Fadlon-Derai, Maggie Gershovitz, Liron Shovali, Amiram Sebbag, Anat Bader, Shakib Fink, Noam Gordon, Barak Myocarditis following COVID-19 vaccination – A case series |
title | Myocarditis following COVID-19 vaccination – A case series |
title_full | Myocarditis following COVID-19 vaccination – A case series |
title_fullStr | Myocarditis following COVID-19 vaccination – A case series |
title_full_unstemmed | Myocarditis following COVID-19 vaccination – A case series |
title_short | Myocarditis following COVID-19 vaccination – A case series |
title_sort | myocarditis following covid-19 vaccination – a case series |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416687/ https://www.ncbi.nlm.nih.gov/pubmed/34535317 http://dx.doi.org/10.1016/j.vaccine.2021.09.004 |
work_keys_str_mv | AT levindan myocarditisfollowingcovid19vaccinationacaseseries AT shimongil myocarditisfollowingcovid19vaccinationacaseseries AT fadlonderaimaggie myocarditisfollowingcovid19vaccinationacaseseries AT gershovitzliron myocarditisfollowingcovid19vaccinationacaseseries AT shovaliamiram myocarditisfollowingcovid19vaccinationacaseseries AT sebbaganat myocarditisfollowingcovid19vaccinationacaseseries AT badershakib myocarditisfollowingcovid19vaccinationacaseseries AT finknoam myocarditisfollowingcovid19vaccinationacaseseries AT gordonbarak myocarditisfollowingcovid19vaccinationacaseseries |